Butrin
Butrin is a compound found in Butea monosperma flowers. Butrin reduces expression of SIRT1, AURKB, cyclin D1, pAKT, GSK-3β, β-catenin, and TGF-3β expression, enhances apoptosis and ROS production in cancer cells. Butrin downregulates Wnt and NF-κB signaling, mitigates oxidative stress, reduces proinflammatory cytokine (TNF-α, IL-6 and IL-8) production and suppresses neuroinflammation. Butrin inhibits IKK enzyme activity. Butrin can be used for the researches of colorectal cancer, Alzheimer’s disease, and rheumatoid arthritis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 492-13-7
- Fòrmula: C27H32O15
- Peso molecular:596.53
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas Aurora Kinase
MoreVer todos los productos específicos de isoformas TNF Receptor
More
Actividad biológica
Descripciòn
IC50 & Target
[1]|
SIRT1 |
Aurora B |
IL-6 |
IL-8 |
In Vitro
Butrin (10-120 μM; 24-48 h) inhibits SW480 human colorectal cancer cell proliferation with an IC50 of 40 μM, while sparing IHH human hepatocyte cells[1].
Butrin (40 μM; 48 h) induces both early and late apoptosis in SW480 human colorectal cancer cells with nuclear condensation and fragmentation[1].
Butrin (40 μM; 48 h) disrupts mitochondrial membrane potential and increases intracellular ROS production in SW480 human colorectal cancer cells[1].
Butrin (40 μM; 48 h) upregulates pro-apoptotic gene expression and downregulates cell cycle and Wnt pathway gene expression in SW480 human colorectal cancer cells[1].
Butrin (40 μM; 48 h) upregulates pro-apoptotic and tumor suppressor protein expression and downregulates anti-apoptotic, cell cycle, and Wnt pathway protein expression in SW480 human colorectal cancer cells[1].
Butrin (1-10 µg/mL; 2-hour pretreatment) inhibits PMACI-induced TNF-α, IL-6 and IL-8 levels and inhibits NF-κB p65 activation in HMC-1 human mast cells[3].
Butrin (5-1000 ng/mL) inhibits recombinant human IKK kinase activity in a concentration-dependent manner[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:SW480 human primary adenocarcinoma colorectal cancer cells; IHH immortalized human hepatocyte cells
-
Concentration:10, 20, 40, 60,120 μM
-
Incubation Time:24 h; 48 h
-
Result:Inhibited SW480 cell proliferation, with an IC50 value of 40 μM against SW480 cells.
Did not induce major cell death in IHH cells.
-
Cell Line:SW480 human primary adenocarcinoma colorectal cancer cells
-
Concentration:40 μM
-
Incubation Time:48 h
-
Result:Induced fragmented green nuclei (early apoptosis) and reddish/orange staining (late apoptosis) in treated cells, whereas control cells had uniformly green viable nuclei.
Induced chromatin condensation and nuclear fragmentation in treated cells, whereas control cells had weak, homogeneous blue-stained nuclei without fragmentation.
Showed nuclear condensation and fragmentation.
-
Cell Line:SW480 human primary adenocarcinoma colorectal cancer cells
-
Concentration:40 μM
-
Incubation Time:48 h
-
Result:Increased mRNA expression of apoptotic genes miR-34a, p53, p21, BAX, caspase 3, and caspase 7.
Decreased mRNA expression of cell cycle/Wnt pathway genes cyclin D1, SIRT1, Aurora B kinase (AURKB), Mdm2, and GSK-3β.
-
Cell Line:SW480 human primary adenocarcinoma colorectal cancer cells
-
Concentration:40 μM
-
Incubation Time:48 h
-
Result:Increased protein expression of cytochrome c, p53, and p21.
Decreased protein expression of procaspase 3, cyclin D1, Cdk4, GSK-3β, β-catenin, pAKT, TGF-3β, SIRT1, and AURKB.
Chemical Information
-
No. CAS 492-13-7
-
Peso molecular 596.53
-
Fòrmula C27H32O15
-
SMILES
O[C@H]1[C@H](OC2=CC3=C(C=C2)C(C[C@@H](C4=CC(O[C@H]5[C@@H]([C@H]([C@@H]([C@@H](CO)O5)O)O)O)=C(O)C=C4)O3)=O)O[C@H](CO)[C@@H](O)[C@@H]1O
-
Structure Classification
-
Initial Source
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocolo
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Collagen-Induced Arthritis
Collagen-induced arthritis (CIA) is an autoimmune murine model of rheumatoid arthritis in which immunization with type II collagen (CII) emulsified in an adjuvant induces a T cell- and autoantibody-driven inflammatory arthritis characterized by synovial hyperplasia, immune cell infiltration, and joint destruction. The model typically relies on genetically susceptible mouse strains (e. g. , DBA/1) and reproduces key features of human rheumatoid arthritis, including anti-collagen immune responses and progressive joint inflammation. Disease onset generally occurs within ~3-4 weeks after immunization, depending on antigen/adjuvant combinations and protocol variation. The immunopathology is driven by adaptive immune activation against CII, leading to systemic and local joint inflammation mediated by pro-inflammatory cytokines and effector immune cells, making CIA a standard preclinical platform for evaluating immunomodulatory and anti-arthritic interventions.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Research Protocol for Neurological Diseases
PINK1/Parkin-mediated mitophagy pathway is a mitochondrial quality-control signaling axis in which mitochondrial depolarization stabilizes PINK1 on damaged mitochondria, activates Parkin recruitment and E3 ubiquitin ligase activity, promotes ubiquitination of outer mitochondrial membrane proteins, recruits selective autophagy adaptors, and drives lysosomal degradation of damaged mitochondria. In neurological disease research, this pathway is experimentally important because neurons, especially dopaminergic neurons, are highly dependent on mitochondrial integrity, and defective mitochondrial turnover can lead to mitochondrial dysfunction, oxidative stress, impaired neuronal survival, α-synuclein accumulation, and neuroinflammatory damage-associated signals. The genetic disease link is strongest in Parkinson’s disease because mutations in PRKN/parkin cause autosomal recessive juvenile parkinsonism, mutations in PINK1 cause hereditary early-onset Parkinson’s disease, and Drosophila studie
Pureza y Documentación
Referencias
[1]. Subramaniyan B, et al. Effect of sodium salt of Butrin, a novel compound isolated from Butea monosperma flowers on suppressing the expression of SIRT1 and Aurora B kinase-mediated apoptosis in colorectal cancer cells. Biomed Pharmacother. 2017;90:402-413. [Content Brief]
[3]. Rasheed Z, et al. Butrin, isobutrin and butein from medicinal plant Butea monosperma selectively inhibit NF-κB in activated human mast cells: suppression of TNF-α, IL-6 and IL-8[J]. J Pharmacol Exp Ther, 2010, 1: 1-34. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Butrin
- 492-13-7
- Sirtuin
- Aurora Kinase
- Akt
- GSK-3
- β-catenin
- TGF-β Receptor
- Apoptosis
- Reactive Oxygen Species (ROS)
- Wnt
- NF-κB
- TNF Receptor
- Interleukin Related
- IKK
- SW480 human colorectal cancer cells
- Parkinson’s disease
- colorectal cancer
- Alzheimer’s disease
- HMC-1 human mast cells
- apoptosis
- IHH human hepatocyte cells
- Wnt signaling
- Inhibitor
- inhibitor
- inhibit